An asthma medication called omalizumab can stop your body from having an allergic response to pollen and even food.

UK biotech Epsilogen has acquired US-based antibody developer TigaTx in a deal that collates work from the two companies’ ...

Learn about anaphylaxis, a severe allergic reaction, its symptoms, causes, diagnosis, treatment, prevention, and importance ...

Research has shed light on how a new type of antibody treatment reactivates patients' immune cells to fight ovarian cancer.

A new study led by researchers at NYU Langone Health has revealed that a special group of cells found in mouse intestines ...

UK biotech Epsilogen has bought US-based TigaTx, pooling their resources to create what it says will be a leader in ...

Study reveals how a new IgE antibody therapy reactivates immune cells, offering a promising approach to fighting ovarian ...

Epsilogen completes acquisition of TigaTx to create world’s leading pan-isotype cancer antibody company: London Tuesday, April 8, 2025, 10:00 Hrs [IST] Epsilogen, the global lea ...

U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “the world’s leading pan-isotype cancer ...

Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibody therapeutics, today announces that it has completed the acquisition of TigaTx, Inc., a biotechnology company ...